PHARMAZZ, INC.

ACTIVE

50 75TH St Ste 105, 伊利诺伊州杜佩奇县, 伊利诺伊州, United Stateswww.pharmazz.comPrivate51–100 employeesEstablished: 2010-01-01

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2010

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

46.1%

Phase 3

30.8%

Phase 4

15.4%

Phase 1

7.7%

Trial Status Distribution

Active, not recruiting

7.7%

Completed

46.1%

Not yet recruiting

15.4%

Recruiting

30.8%

Clinical Trials

Trials sponsored by this organization (13)

Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS

Phase 2

Not yet recruiting

interventional

May 202780 participants

A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent

Phase 3

Not yet recruiting

interventional

Feb 2027430 participants

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Phase 3

Recruiting

interventional

Jul 2025514 participants

Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Phase 4

Active, not recruiting

interventional

Jan 2024160 participants

Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy

Phase 2

Recruiting

interventional

Sep 202340 participants

A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients

Phase 4

Recruiting

interventional

Aug 2021400 participants

Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke

Phase 3

Completed

interventional

Nov 2019158 participants

Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock

Phase 3

Completed

interventional

Jan 2019105 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations